T-cells in angiotensin-II-induced vascular damage.
Geiger
Helmut
H
Helmut Geiger, Division of Nephrology, Department of Internal Medicine, Johann Wolfgang Goethe-University Frankfurt/Main, Theodor-Stern Kai 7, 60590 Frankfurt, Germany. h.geiger@em.uni-frankfurt.de
Helmut
Geiger
G
D000804:Angiotensin II / Q000009:adverse effects*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects* / Q000503:physiopathology; D018946:Chemokine CCL5 / Q000096:biosynthesis / Q000187:drug effects; D018450:Disease Progression; D006801:Humans; D006977:Hypertension, Renal / Q000276:immunology* / Q000503:physiopathology; D007111:Immunity, Cellular / Q000187:drug effects*; D013601:T-Lymphocytes / Q000276:immunology*; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D018946:Chemokine CCL5; D014662:Vasoconstrictor Agents; D000804:Angiotensin II